News Image

OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Provided By GlobeNewswire

Last update: Mar 10, 2025

— PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary data in December 2024

Read more at globenewswire.com

ONKURE THERAPEUTICS INC-A

NASDAQ:OKUR (12/12/2025, 8:00:01 PM)

After market: 3.1128 +0.04 (+1.39%)

3.07

-0.16 (-4.95%)



Find more stocks in the Stock Screener

Follow ChartMill for more